The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer
- 28 May 2010
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 321 (1), 50-56
- https://doi.org/10.1016/j.mce.2009.10.013
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- The Role of the PAX8/PPARFusion Oncogene in Thyroid CancerPPAR Research, 2008
- Peroxisome Proliferator-Activated Receptor-δ Induces Cell Proliferation by a Cyclin E1–Dependent Mechanism and Is Up-regulated in Thyroid TumorsCancer Research, 2008
- Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid NeoplasiaEndocrinology and Metabolism Clinics of North America, 2008
- BRAFV600E Mutation Is Associated with Preferential Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibition in Thyroid Cancer Cell LinesJournal of Clinical Endocrinology & Metabolism, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- PAX8PPARγ Stimulates Cell Viability and Modulates Expression of Thyroid-Specific Genes in a Human Thyroid Cell LineThyroid®, 2007
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- PAX8-PPARγ Rearrangement Is Frequently Detected in the Follicular Variant of Papillary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2006
- Regulation of Gene Expression by Activation of the Peroxisome Proliferator-Activated Receptor γ with Rosiglitazone (BRL 49653) in Human AdipocytesBiochemical and Biophysical Research Communications, 1999
- Inhibition of Adipogenesis by a COOH-Terminally Truncated Mutant of PPARγ2 in 3T3-L1 CellsBiochemical and Biophysical Research Communications, 1999